At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Statin Therapy to Reduce the Risk of Recurrent Pancreatitis
In Brief
A Phase 2 clinical trial evaluating Laboratory Biomarker Analysis, Placebo Administration, and 3 other interventions for Acute Pancreatitis. Completed, enrolled 8 participants across 5 sites.
Detailed Summary
This randomized phase II trial studies how well simvastatin works in reducing pancreatitis (the inflammation of the pancreas) in patients with pancreatitis that occurs more than once (recurrent), has worsened quickly (acute), or has persisted or progressed over a long period of time (chronic). Simvastatin may decrease the inflammation of the pancreas by modulating the immune response responsible for inflammation. It is not yet known if simvastatin may be an effective treatment for pancreatitis.
Study Details
Timeline
Interventions
Correlative studies
Given PO
Ancillary studies
Ancillary studies
Given PO